Milestone Reimbursement Assessment

Do you need to make a development milestone decision for a product? Has reimbursement been considered?

In the clinical development process for a product, companies establish points in time where they look at their clinical development to determine the best path forward. This is an ideal time to have DK Pierce & Associates provide an extensive analysis on what is happening in the reimbursement environment that could affect development decisions. We delve into issues such as:

1. What does reimbursement look like for the current formulation, dosing schema?
2. Is reimbursement an issue in the targeted indications? Is one area more scrutinized than another?
3. Will the clinical trial endpoints provide the data that payers will need to determine positive coverage and reimbursement?